Accordingly, we observed a significantly higher abundance of CD69 T cells in the spleen of SUMOi-treated mice (Figure 8, E and F), which is in line with our previous data that SUMOi activates tumor-infiltrating CD8+ T cells (Figure 4F). The gene discussed is CD8A; the disease is neoplasm.